5 unknown, 2 not yet recruiting, 1 completed, 1 recruiting. 9 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Unknown 5, Not yet recruiting 2, Completed 1, Recruiting 1 |
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
Follow Spermine Synthase: new trials by email Literature Review of Spermine Synthase trials Research Report on Spermine Synthase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets Ivonescimab, Carboplatin, Pemetrexed - Non Small Cell Lung Cancer | Phase 2 | Not yet recruiting | European Organisation for Research and Treatment of Cancer - EORTC | 158 | 2026-11-01 | 2026-06-04 |
| A Study to Investigate Small Mobile Stem Cells (SMS) in Moderate to Severe Chronic Obstructive Pulmonary Disease Stem cells - Chronic Obstructive Lung Disease | Phase 1 / Phase 2 | Not yet recruiting | SMSbiotech | 125 | 2026-10-01 | 2026-10-13 |
| Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases Cadonilimab combined with SRS - Non Small Cell Lung Cancer, Brain Metastases | Phase 2 | Recruiting | Rongrong Zhou | 20 | 2024-11-01 | 2024-11-25 |
| TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine TTFields and SRS - Glioblastoma Multiforme, Recurrent Glioblastoma | Phase 2 | Unknown | Prof. Franciszek Lukaszczyk Memorial Oncology Center | 40 | 2020-12-26 | 2023-06-28 |
| Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation Icotinib, WBRT or SRS - Non-Small Cell Lung Cancer, Brain Metastases | Phase 2 | Unknown | Betta Pharmaceuticals Co., Ltd. | 162 | 2018-12-01 | 2018-11-27 |
| Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors Indoximod, Temozolomide, Bevacizumab - Glioblastoma Multiforme, Glioma | Phase 1 / Phase 2 | Completed | NewLink Genetics Corporation | 160 | 2014-03-01 | 2024-03-27 |
| Follow-up of Children After Stuttering Treatment SMS (Short Message Service) reminders - Stuttering | Phase 2 | Unknown | University of Sydney | 180 | 2009-02-01 | 2010-04-26 |
| Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy. 2-(5-fluoro-pentyl)-2-methyl-malonic-acid ([18F]-ML-10), Stereotactic Radio-Surgery (SRS) therapy, Positron Emission Tomography - Brain Metastases, Solid Tumors | Phase 2 | Unknown | Aposense Ltd. | 30 | 2008-11-01 | 2010-05-12 |
| Definitive Therapy for Oligometastatic Solid Malignancies Complete Surgical Removal, Stereotactic Radiosurgery, Ablative external beam radiation dose - Stage IV or Recurrent Carcinoma or Sarcoma | Phase 2 | Unknown | Rocky Mountain Cancer Centers | 110 | 2005-12-01 | 2013-07-15 |
Brain Neoplasms (4) · Carcinoma, Non-Small-Cell Lung (3) · Recurrence (3) · Glioblastoma (2) · Glioma (1) · Gliosarcoma (1) · Neoplasm Metastasis (1) · Pulmonary Disease, Chronic Obstructive (1) · Sarcoma (1) · Stuttering (1)
Aposense Ltd. (1) · Betta Pharmaceuticals Co., Ltd. (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · NewLink Genetics Corporation (1) · Prof. Franciszek Lukaszczyk Memorial Oncology Center (1) · Rocky Mountain Cancer Centers (1) · Rongrong Zhou (1) · SMSbiotech (1) · University of Sydney (1)
United States (4) · Australia (1) · Austria (1) · China (1) · France (1) · Germany (1) · Greece (1) · Italy (1) · Netherlands (1) · Poland (1) · Slovenia (1) · Spain (1)
Dennise Carter, MD (1) · Lizza Hendriks, MD, PhD (1) · Maciej Harat, MD PhD (1) · Mark Onslow, PhD (1) · Trishul Siddharthan, Medical Doctor (1)